Xi'an Key Laboratory for Prevention and Treatment of Common Aging Diseases, Translational and Research Centre for Prevention and Therapy of Chronic Disease, Institute of Basic and Translational Medicine, Xi'an Medical University, Xi'an, 710021, PR China.
The First Affiliated Hospital of Xi'an Medical College, Xi'an Medical University, Xi'an, 710021, China.
Cardiovasc Diabetol. 2024 Apr 15;23(1):128. doi: 10.1186/s12933-024-02205-2.
Compelling evidence suggests that calcium/phosphorus homeostasis-related parameters may be linked to diabetes mellitus and cardiovascular events. However, few studies have investigated the association of fibroblast growth factor 23 (FGF23), α-klotho and FGF23/α-klotho ratio with atherosclerosis in patients with type 2 diabetes mellitus (T2DM).
This study was designed to evaluate whether FGF23, α-klotho and FGF23/α-klotho ratio are associated with T2DM and further to explore the relationships between these three factors and atherosclerosis in Chinese patients with T2DM.
Serum FGF23 and α-klotho levels were measured via an enzyme-linked immunosorbent assay (ELISA) kit, and the carotid intima-media thickness (CIMT) was assessed via high-resolution color Doppler ultrasonography. The associations of serum FGF23, α-klotho and FGF23/α-klotho ratio with atherosclerosis in T2DM patients were evaluated using multivariable logistic regression models.
This cross-sectional study involved 403 subjects (207 with T2DM and 196 without T2DM), 41.7% of the patients had atherosclerosis, and 67.2% of the carotid intima were thickened to a thickness greater than 0.9 mm. Compared with those in the lowest tertile, higher tertiles of FGF23 levels and FGF23/α-klotho ratio were positively associated with T2DM after adjusting for covariates, and serum α-klotho concentration was inversely correlated with T2DM (all P values < 0.01). Moreover, elevated serum FGF23 levels and FGF23/α-klotho ratio were positively associated with CIMT and carotid atherosclerosis in T2DM patients (all P values < 0.01). Further spline analysis similarly revealed linear dose‒response relationship (all P values < 0.01). And there was still significant differences in CIMT and carotid atherosclerosis between the highest group of α-klotho and the reference group in T2DM patients (P values = 0.05).
T2DM was positively linearly related to serum FGF23 concentration and FGF23/α-klotho ratio, and negatively correlated with serum α-klotho concentration. Furthermore, both FGF23 and FGF23/α-klotho ratio were positively correlated with CIMT and atherosclerosis in T2DM patients, while α-klotho was inversely correlated with both CIMT and atherosclerosis, although the associations were not completely significant. Prospective exploration and potential mechanisms underlying these associations remain to be further elucidated.
大量证据表明钙磷稳态相关参数可能与糖尿病和心血管事件有关。然而,很少有研究调查成纤维细胞生长因子 23(FGF23)、α-klotho 和 FGF23/α-klotho 比值与 2 型糖尿病(T2DM)患者动脉粥样硬化之间的关系。
本研究旨在评估 FGF23、α-klotho 和 FGF23/α-klotho 比值是否与 T2DM 相关,并进一步探讨这三个因素与中国 T2DM 患者动脉粥样硬化之间的关系。
采用酶联免疫吸附试验(ELISA)试剂盒测定血清 FGF23 和 α-klotho 水平,采用高分辨率彩色多普勒超声评估颈动脉内膜中层厚度(CIMT)。采用多变量 logistic 回归模型评估血清 FGF23、α-klotho 和 FGF23/α-klotho 比值与 T2DM 患者动脉粥样硬化之间的关系。
这项横断面研究共纳入 403 名受试者(207 名 T2DM 患者和 196 名非 T2DM 患者),41.7%的患者有动脉粥样硬化,67.2%的颈动脉内膜增厚至大于 0.9mm。与最低三分位组相比,调整协变量后,较高三分位组的 FGF23 水平和 FGF23/α-klotho 比值与 T2DM 呈正相关,血清 α-klotho 浓度与 T2DM 呈负相关(均 P 值<0.01)。此外,升高的血清 FGF23 水平和 FGF23/α-klotho 比值与 T2DM 患者的 CIMT 和颈动脉粥样硬化呈正相关(均 P 值<0.01)。进一步的样条分析同样显示出线性剂量反应关系(均 P 值<0.01)。并且在 T2DM 患者中,α-klotho 最高组与参考组之间的 CIMT 和颈动脉粥样硬化仍存在显著差异(P 值=0.05)。
T2DM 与血清 FGF23 浓度和 FGF23/α-klotho 比值呈正线性相关,与血清 α-klotho 浓度呈负相关。此外,FGF23 和 FGF23/α-klotho 比值与 T2DM 患者的 CIMT 和动脉粥样硬化均呈正相关,而 α-klotho 与 CIMT 和动脉粥样硬化均呈负相关,尽管关联并不完全显著。这些关联的潜在机制仍有待进一步阐明。